On Monday, GeneDx Holdings Corp (NASDAQ: WGS) was -1.59% drop from the session before settling in for the closing price of $67.23. A 52-week range for WGS has been $18.80 – $117.75.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 16.51% over the last five years. When this article was written, the company’s average yearly earnings per share was at 332.12%. With a float of $24.94 million, this company’s outstanding shares have now reached $28.53 million.
The firm has a total of 1000 workers. Let’s measure their productivity. In terms of profitability, gross margin is 63.93%, operating margin of -4.2%, and the pretax margin is -11.62%.
GeneDx Holdings Corp (WGS) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward GeneDx Holdings Corp stocks. The insider ownership of GeneDx Holdings Corp is 12.60%, while institutional ownership is 84.24%. The most recent insider transaction that took place on Apr 29 ’25, was worth 43,879. In this transaction CHIEF FINANCIAL OFFICER of this company sold 388 shares at a rate of $113.09, taking the stock ownership to the 3,337 shares. Before that another transaction happened on Apr 29 ’25, when Company’s Chief Executive Officer sold 2,154 for $113.09, making the entire transaction worth $243,596. This insider now owns 3,440 shares in total.
GeneDx Holdings Corp (WGS) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.27 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 332.12% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 122.09% during the next five years compared to 96.65% growth over the previous five years of trading.
GeneDx Holdings Corp (NASDAQ: WGS) Trading Performance Indicators
You can see what GeneDx Holdings Corp (WGS) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 3.07. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.72.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.44, a number that is poised to hit 0.13 in the next quarter and is forecasted to reach 2.05 in one year’s time.
Technical Analysis of GeneDx Holdings Corp (WGS)
Analysing the last 5-days average volume posted by the [GeneDx Holdings Corp, WGS], we can find that recorded value of 3.23 million was better than the volume posted last year of 1.14 million. As of the previous 9 days, the stock’s Stochastic %D was 6.50%. Additionally, its Average True Range was 10.07.
During the past 100 days, GeneDx Holdings Corp’s (WGS) raw stochastic average was set at 12.75%, which indicates a significant increase from 8.19% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 243.13% in the past 14 days, which was higher than the 136.97% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $93.87, while its 200-day Moving Average is $68.29. Now, the first resistance to watch is $67.79. This is followed by the second major resistance level at $69.41. The third major resistance level sits at $71.46. If the price goes on to break the first support level at $64.12, it is likely to go to the next support level at $62.07. Should the price break the second support level, the third support level stands at $60.45.
GeneDx Holdings Corp (NASDAQ: WGS) Key Stats
There are 28,068K outstanding shares of the company, which has a market capitalization of 1.89 billion. As of now, sales total 305,450 K while income totals -52,290 K. Its latest quarter income was 95,640 K while its last quarter net income were 5,440 K.
